A Randomized, Single-Blind, Active-Controlled, Dose-Ranging Study To Evaluate PK, Safety, and Efficacy of Local Administration of DepoTXA for Reduced Post-Surgical Bleeding in Subjects Undergoing TKA
Phase of Trial: Phase II
Latest Information Update: 18 Dec 2017
At a glance
- Drugs Tranexamic acid (Primary)
- Indications Haemorrhage
- Focus Therapeutic Use
- Sponsors Pacira Pharmaceuticals
- 11 Dec 2017 Status changed from recruiting to discontinued.
- 12 Oct 2017 Planned End Date changed from 1 Jul 2017 to 1 Jun 2018.
- 12 Oct 2017 Planned primary completion date changed from 1 Jul 2017 to 1 Mar 2018.